1. Academic Validation
  2. Discovery of dual tubulin-NEDDylation inhibitors with antiproliferative activity

Discovery of dual tubulin-NEDDylation inhibitors with antiproliferative activity

  • J Enzyme Inhib Med Chem. 2023 Dec;38(1):166-175. doi: 10.1080/14756366.2022.2136173.
Dong-Jun Fu 1 Ting Wang 1
Affiliations

Affiliation

  • 1 Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Abstract

Although various dual-target tubulin inhibitors have been designed and synthesised, no dual tubulin-NEDDylation inhibitors as antiproliferative agents were reported so far. In this work, a series of trimethoxyphenyl analogues as potential dual tubulin-NEDDylation inhibitors were synthesised and evaluated for their antiproliferative activity. Among them, compound C11 exhibited the most potent inhibitory activity with IC50 values of 1.17, 2.48, and 1.47 μM against HepG2, PC3, and MCF7 cells, respectively. In addition, it displayed the potent inhibitory activity against tubulin with an IC50 value of 2.40 μM and obviously inhibited tubulin polymerisation in HepG2 cells. Furthermore, C11 inhibited NEDDylation by a ATP-dependent manner. Molecular docking studies revealed that the methoxy group and dithiocarbamate group of C11 could form hydrogen bonds with residues of tubulin and E1 NEDD8-activating Enzyme (NAE). These results suggested that compound C11 was a dual tubulin-NEDDylation inhibitor with antiproliferative activity.

Keywords

NEDDylation; Tubulin; antiproliferative activity; molecular docking.

Figures
Products